Original Article
Copyright ©2010 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 21, 2010; 16(47): 5975-5981
Published online Dec 21, 2010. doi: 10.3748/wjg.v16.i47.5975
Figure 1
Figure 1 Expression of cyclooxygenase-2 in normal esophageal mucosa and esophageal squamous cell carcinoma. Positive staining in cytoplasm in normal mucosa (A), well-differentiated squamous cell carcinoma (SCC) (B) and poorly-differentiated SCC (C). Counterstaining with hematoxylin, × 200.
Figure 2
Figure 2 Expression of Ki-67 in normal esophageal mucosa and esophageal squamous cell carcinoma. Positive nuclei staining in normal esophageal mucosa (A, × 100), well-differentiated (B, × 200) and poorly-differentiated squamous cell carcinoma (C, × 200). Counterstaining with hematoxylin.
Figure 3
Figure 3 Expression of cyclin A in normal esophageal mucosa and esophageal squamous cell carcinoma. Positive nuclei staining in normal esophageal mucosa (A, × 100), well-differentiated (B, × 200) and poorly-differentiated squamous cell carcinoma (C, × 200). Counterstaining with hematoxylin.
Figure 4
Figure 4 Expression of p27 in normal esophageal mucosa and esophageal squamous cell carcinoma. Sections stained with anti-p27 antibody showing nuclear staining (brown) in normal esophageal mucosa (A, × 100), well-differentiated (B, × 200) and poorly-differentiated squamous cell carcinoma (C, × 200). Counterstaining with hematoxylin.